IA
DXCM icon

IndexIQ Advisors’s DexCom DXCM Stock Holding History

IndexIQ Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$889K Buy
6,948
+528
+8% +$57.8K 0.03% 296
2021
Q4 		$862K Sell
6,420
-244
-4% -$35.1K 0.03% 328
2021
Q3 		$911K Buy
6,664
+328
+5% +$41.4K 0.03% 316
2021
Q2 		$676K Buy
6,336
+232
+4% +$22.3K 0.02% 366
2021
Q1 		$548K Buy
6,104
+784
+15% +$73.6K 0.02% 362
2020
Q4 		$492K Buy
+5,320
New +$475K 0.02% 392

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IndexIQ Advisors's DXCM Position: Q1 2022 in Review

IndexIQ Advisors increased its DexCom (DXCM) stake by 8.2% in Q1 2022, buying an estimated $57.8K and bringing the position to 6,948 shares worth $889K. The position accounts for 0.03% of the portfolio, ranked #296.

IndexIQ Advisors first reported a position in DXCM in Q4 2020 and has held it in 6 quarters since. The position peaked at $911K in Q3 2021. 861 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

  • IndexIQ Advisors held 6,948 shares of DexCom worth $889K as of Q1 2022.
  • IndexIQ Advisors bought 528 DexCom shares in Q1 2022, an estimated $57.8K.
  • DexCom made up 0.03% of IndexIQ Advisors's portfolio in Q1 2022, its #296 holding.
  • IndexIQ Advisors first reported a position in DexCom in Q4 2020 and has held it in 6 quarters since.
  • IndexIQ Advisors's DexCom position peaked at $911K in Q3 2021.
  • 861 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.